Cheyne Capital Management (UK) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Iovance Biotherapeutics
IOVA
|
+$2.84M |
| 2 |
Copart
CPRT
|
+$2.69M |
| 3 |
GTT
GTT Communications, Inc.
GTT
|
+$2.54M |
| 4 |
B
Barrick Mining
B
|
+$1.9M |
| 5 |
Carvana
CVNA
|
+$1.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$1.32M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$972K |
| 3 |
Vanda Pharmaceuticals
VNDA
|
+$781K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 6.85% |
| 2 | Healthcare | 5.63% |
| 3 | Communication Services | 4.67% |
| 4 | Financials | 2.48% |
| 5 | Materials | 1.61% |
Similar funds
Cheyne Capital Management (UK)'s Q3 2018 Portfolio in Review
As of Q3 2018, Cheyne Capital Management (UK) held 44 positions worth $168M, up 20% from $140M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Cheyne Capital Management (UK) withdrew a net $104M in Q3 2018, closing 3 positions. Its most notable exit was AT&T, an estimated $1.32M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 6.9% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Cheyne Capital Management (UK) opened a new position in Iovance Biotherapeutics worth $2.25M.
- Cheyne Capital Management (UK)'s largest Q3 2018 buy was Iovance Biotherapeutics: 200,000 shares worth $2.25M.
- Cheyne Capital Management (UK) added most to GTT Communications, Inc. in Q3 2018, an estimated $2.54M increase.
- Cheyne Capital Management (UK) fully exited AT&T in Q3 2018, selling an estimated $1.32M.
- Cheyne Capital Management (UK)'s ten largest holdings make up 47% of its $168M portfolio in Q3 2018.
- Cheyne Capital Management (UK) opened 7 new positions and closed 3 in Q3 2018.
- Cheyne Capital Management (UK)'s portfolio value rose 20% quarter-over-quarter to $168M.
Based on Cheyne Capital Management (UK)'s 13F filing for Q3 2018, filed 5 Nov 2018.